Scienture (SCNX) announced that Arbli Oral Suspension, 10 mg/mL has been added to the formularies of key national payors, expanding access through ...
Scienture's Arbli losartan oral suspension gains access to over 100 million covered lives through national commercial and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback